This article has expired, however you can still
download the PDF.
Preview:
Company will develop Pancreatic Cancer Profiler based on technology
to identify drug responders for therapeutic development
GeneCentric Therapeutics, Inc. today announced that the company has
acquired an exclusive license fr...